Citadel Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$778K Sell
10,919
-21,534
-66% -$1.47M ﹤0.01% 8253
2025
Q4
$1.92M Sell
32,453
-29,994
-48% -$1.63M ﹤0.01% 5997
2025
Q3
$3.45M Sell
62,447
-12,328
-16% -$641K ﹤0.01% 5046
2025
Q2
$3.22M Buy
74,775
+32,520
+77% +$1.25M ﹤0.01% 4861
2025
Q1
$1.67M Buy
42,255
+32,819
+348% +$1.45M ﹤0.01% 5890
2024
Q4
$385K Sell
9,436
-23,222
-71% -$967K ﹤0.01% 9141
2024
Q3
$1.27M Sell
32,658
-60,575
-65% -$2.41M ﹤0.01% 6368
2024
Q2
$4.08M Sell
93,233
-33,554
-26% -$1.62M ﹤0.01% 4068
2024
Q1
$6.05M Buy
126,787
+106,910
+538% +$4.81M ﹤0.01% 3645
2023
Q4
$939K Sell
19,877
-7,919
-28% -$329K ﹤0.01% 6798
2023
Q3
$1.32M Sell
27,796
-21,344
-43% -$1.17M ﹤0.01% 6015
2023
Q2
$2.86M Buy
49,140
+18,744
+62% +$1.12M ﹤0.01% 4553
2023
Q1
$2.17M Sell
30,396
-13,641
-31% -$1.08M ﹤0.01% 5199
2022
Q4
$3.1M Sell
44,037
-104,368
-70% -$7.36M ﹤0.01% 4701
2022
Q3
$9M Buy
148,405
+26,354
+22% +$1.77M ﹤0.01% 2925
2022
Q2
$7.71M Buy
122,051
+92,294
+310% +$6.01M ﹤0.01% 3033
2022
Q1
$1.91M Buy
+29,757
New +$1.99M ﹤0.01% 6195
2021
Q4
Sell
-5,160
Closed -$392K 14424
2021
Q3
$368K Buy
+5,160
New +$407K ﹤0.01% 10594
2021
Q2
Sell
-15,950
Closed -$1.28M 14147
2021
Q1
$1.21M Buy
+15,950
New +$1.16M ﹤0.01% 7635
2020
Q4
Sell
-143,817
Closed -$9.37M 11307
2020
Q3
$7.11M Sell
143,817
-89,000
-38% -$5.02M ﹤0.01% 2681
2020
Q2
$12.2M Buy
232,817
+28,350
+14% +$1.35M ﹤0.01% 1998
2020
Q1
$7.2M Buy
204,467
+110,623
+118% +$6.46M ﹤0.01% 2249
2019
Q4
$8.2M Buy
93,844
+7,495
+9% +$655K ﹤0.01% 2441
2019
Q3
$7.33M Buy
86,349
+80,189
+1,302% +$7.14M ﹤0.01% 2606
2019
Q2
$648K Sell
6,160
-84,816
-93% -$8.52M ﹤0.01% 6404
2019
Q1
$9.61M Buy
+90,976
New +$9.14M ﹤0.01% 2129
2018
Q4
Sell
-3,669
Closed -$332K 9553
2018
Q3
$374K Sell
3,669
-1,067
-23% -$103K ﹤0.01% 7205
2018
Q2
$383K Buy
+4,736
New +$376K ﹤0.01% 6805
2018
Q1
Sell
-33,737
Closed -$2.52M 8605
2017
Q4
$2.38M Buy
33,737
+18
+0.1% +$1.3K ﹤0.01% 3389
2017
Q3
$2.11M Buy
33,719
+5,947
+21% +$352K ﹤0.01% 3352
2017
Q2
$1.59M Buy
+27,772
New +$1.63M ﹤0.01% 3451
2016
Q3
Sell
-31,708
Closed -$1.08M 7574
2016
Q2
$1.08M Buy
+31,708
New +$990K ﹤0.01% 3457

Other funds holding NGVT

Citadel Advisors's NGVT Position: Q1 2026 in Review

Citadel Advisors reduced its Ingevity (NGVT) stake by 66% in Q1 2026, selling an estimated $1.47M and leaving 10,919 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #8253.

Citadel Advisors first reported a position in NGVT in Q2 2016 and has held it in 32 quarters since. The position peaked at $12.2M in Q2 2020. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Citadel Advisors held 10,919 shares of Ingevity worth $778K as of Q1 2026.
  • Citadel Advisors sold 21,534 Ingevity shares in Q1 2026, an estimated $1.47M.
  • Ingevity made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8253 holding.
  • Citadel Advisors first reported a position in Ingevity in Q2 2016 and has held it in 32 quarters since.
  • Citadel Advisors's Ingevity position peaked at $12.2M in Q2 2020.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.